These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32277784)

  • 1. Approaching altered inhibitory control in phenylketonuria: A functional MRI study with a Go-NoGo task in young female adults.
    Sundermann B; Garde S; Dehghan Nayyeri M; Weglage J; Rau J; Pfleiderer B; Feldmann R
    Eur J Neurosci; 2020 Oct; 52(8):3951-3962. PubMed ID: 32277784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural correlates of working memory and its association with metabolic parameters in early-treated adults with phenylketonuria.
    Abgottspon S; Muri R; Christ SE; Hochuli M; Radojewski P; Trepp R; Everts R
    Neuroimage Clin; 2022; 34():102974. PubMed ID: 35248901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory control in young adult women with fetal alcohol syndrome: Findings from a pilot functional magnetic resonance imaging study.
    Rau JMH; Sundermann B; Pfleiderer B; Dehghan-Nayyeri M; Garde S; Weglage J; Feldmann R
    Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):600-612. PubMed ID: 36807201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.
    Sundermann B; Pfleiderer B; Möller HE; Schwindt W; Weglage J; Lepsien J; Feldmann R
    J Inherit Metab Dis; 2011 Jun; 34(3):711-21. PubMed ID: 21491106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?
    Stevenson M; McNaughton N
    Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Event-related potentials elicited during a visual Go-Nogo task in adults with phenylketonuria.
    Moyle JJ; Fox AM; Bynevelt M; Arthur M; Burnett JR
    Clin Neurophysiol; 2006 Oct; 117(10):2154-60. PubMed ID: 16920019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust dissociation among the language, multiple demand, and default mode networks: Evidence from inter-region correlations in effect size.
    Mineroff Z; Blank IA; Mahowald K; Fedorenko E
    Neuropsychologia; 2018 Oct; 119():501-511. PubMed ID: 30243926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted intrinsic functional connectivity of the cognitive control network underlies disease severity and executive dysfunction in first-episode, treatment-naive adolescent depression.
    Pan F; Xu Y; Zhou W; Chen J; Wei N; Lu S; Shang D; Wang J; Huang M
    J Affect Disord; 2020 Mar; 264():455-463. PubMed ID: 31780136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White and gray matter brain development in children and young adults with phenylketonuria.
    Hawks Z; Hood AM; Lerman-Sinkoff DB; Shimony JS; Rutlin J; Lagoni D; Grange DK; White DA
    Neuroimage Clin; 2019; 23():101916. PubMed ID: 31491833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
    Brumm VL; Azen C; Moats RA; Stern AM; Broomand C; Nelson MD; Koch R
    J Inherit Metab Dis; 2004; 27(5):549-66. PubMed ID: 15669671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical thickness and its relationship to cognitive performance and metabolic control in adults with phenylketonuria.
    Muri R; Maissen-Abgottspon S; Rummel C; Rebsamen M; Wiest R; Hochuli M; Jansma BM; Trepp R; Everts R
    J Inherit Metab Dis; 2022 Nov; 45(6):1082-1093. PubMed ID: 36117142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis.
    Fryer SL; Roach BJ; Ford JM; Donaldson KR; Calhoun VD; Pearlson GD; Kiehl KA; Srihari VH; McGlashan TH; Woods SW; Mathalon DH
    Schizophr Bull; 2019 Jan; 45(1):158-168. PubMed ID: 29385625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R; Osterloh J; Onon S; Fromm J; Rutsch F; Weglage J
    Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive response monitoring and inhibitory control in children with phenylketonuria: effects of expectancy.
    Araujo GC; Christ SE; Grange DK; Steiner RD; Coleman C; Timmerman E; White DA
    Dev Neuropsychol; 2013; 38(3):139-52. PubMed ID: 23573793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.